USPTO serial 78565990
AGENA
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- RINGLE, JAMES W
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with AGENA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeffrey L. Van Hoosear, Esq.
JEFFREY L VAN HOOSEAR ESQ KNOBBE, MARTENS, OLSON & BEAR LLP2040 MAIN ST FL 14IRVINE, CA 92614-7216UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals used in industry, science and agriculture, namely, nucleic acid sequences, chemical reagents and biological reagents, namely, Peptide sequences, antibodies and media preparations not for medical and veterinary purposes; and chemical substances and preparations for research and industrial laboratory use | ACTIVE | — |
| 005 | Pharmaceutical, medical, veterinary and sanitary preparations, namely, cellular therapeutic products, combinational therapies which include or comprise of cell products and other molecules, bioreactors including polymers and bioactive surfaces, stem cell products, blood products and agents or molecules that modulate stem cells; chemical preparations and substances for medical use; diagnostic preparations and reagents for medical use; culture fluids, namely, cultures of micro-organisms for medical purposes; biological human tissue and animal tissue namely, bone and skin tissue for subsequent transplantation purposes; human cells and animal cells for medical or clinical use; pharmaceutical preparations for the treatment, reconstruction and repair of skin and bone tissue; and surgical implants comprising living tissue | ACTIVE | — |
| 009 | Scientific, electric, and teaching apparatus, namely, informational CDs and instruments, namely, kits comprised of a set of laboratory instruments and enzymes for stem cell identification and isolation for use in the fields of biology, medicine, gene technology, stem cells, transplantation, tissue engineering and repair, immune modulation, and wound healing; apparatus for recording, transmission or reproduction of sound or images for use in the fields of biology, medicine, gene technology, stem cells, transplantation, tissue engineering and repair, immune modulation, and wound healing; scanners; blank magnetic data carriers and pre-recorded magnetic data carriers in the field of biology, medicine, gene technology, stem cells, transplantation, tissue engineering and repair, immune modulation, and wound healing, blank optical recording discs; data processors and computers; educational computer software for use in the field of biology, medicine, gene technology, stem cells research, transplantation, tissue engineering and repair, immune modulation, and wound healing electronic and computer related materials in this class, namely electronic or multimedia publications, namely, books and magazines featuring biology, medicine, gene technology, stem cells, transplantation, tissue engineering and repair, immune modulation, and wound healing recorded on computer media; downloadable electronic publications in the nature of journals and magazines in the field of biology, medicine, gene technology, stem cells, transplantation, tissue engineering and repair, immune modulation, and wound healing | ACTIVE | — |
| 010 | Surgical, medical, dental and veterinary apparatus and instruments, namely, cell sorting apparatus and instruments and bioreactors for cell culture and purification for use in the fields of biology, medicine, gene technology, stem cells, transplantation, tissue engineering and repair, immune modulation, and wound healing and parts and fittings therefore; surgical and medical implants comprising artificial or biological material in the fields of tissue repair and cell implantation and implantable bioreactors for use in the fields of biology, medicine, gene technology, stem cells, transplantation, tissue engineering and repair, immune modulation, and wound healing | ACTIVE | — |
| 016 | Printed matter and publications, namely, a series informational brochures, books, journals and informational pamphlets featuring scientific research in the fields of biology, medicine, gene technology, stem cells, transplantation, tissue engineering and repair, immune modulation and wound healing | ACTIVE | — |
| 040 | Custom design and manufacture of medical instruments, devices and equipment made to the order or specification of others; contract manufacturing for others in the field of pharmaceutical products; and chemical treatment and transformation for others of organic substances | ACTIVE | — |
| 041 | Educational and training services, namely, providing courses of instruction for doctors and medical personnel in the fields of biology, medicine, gene technology, stem cells, transplantation, tissue engineering and repair, immune modulation and wound healing; educational information in the nature of seminars in the field of biology, medicine, gene technology, stem cells, transplantation, tissue engineering and repair, and wound healing via the internet; educational services, namely, arranging and conducting seminars, congresses, symposiums, conferences and workshops in the field of biology, medicine, gene technology, stem cells, transplantation, tissue engineering and repair, immune modulation and wound healing; conducting and organizing exhibitions for educational purposes in the fields of biology, medicine, gene technology, stem cells, transplantation, tissue engineering and repair, immune modulation and wound healing; online education and training services, namely, conducting courses and classes in the fields of biology, medicine, gene technology, stem cells, transplantation, tissue engineering and repair, immune modulation and wound healing via the global computer network, telephone network, wireless connections and interactive web sites; publication of books, magazines and journals; electronic publishing services, namely, publication of text and graphic works or other works in print, on CD, DVD or on-line featuring information in the fields of biology, medicine, gene technology, stem cells, transplantation, tissue engineering and repair, immune modulation and wound healing | ACTIVE | — |
| 042 | Research and development services, namely, medical, surgical, veterinary, scientific and industrial research and development services in the fields of gene technology, stem cells, transplantations, tissue engineering and repair, immune modulation and wound healing; advisory and consultancy services relating to the aforementioned services; design and development of computer software relating to the field of science and medicine for others; maintenance of computer software in the field of science and medicine | ACTIVE | — |
| 044 | Medical and veterinarian services; medical, pharmacy and veterinarian advice and consultancy services; medical advice services for scientific and industrial research; medical services relating to stem cells, transplantation, tissue engineering and repair, and wound healing | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Australian Stem Cell Centre Limited
- Other trademarks owned by Australian Stem Cell Centre Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 016
- Other trademarks in Class 040
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named AGENA
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 17, 2009 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 17, 2009 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Dec 29, 2008 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Dec 29, 2008 | EXT2 | SOU EXTENSION 2 FILED | — |
| Dec 29, 2008 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 11, 2008 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jul 11, 2008 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jul 11, 2008 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 20, 2008 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Jan 15, 2008 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 23, 2007 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 3, 2007 | NPUB | NOTICE OF PUBLICATION | — |
| Sep 18, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Sep 17, 2007 | ALIE | ASSIGNED TO LIE | — |
| Aug 9, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 9, 2007 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 9, 2007 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 9, 2007 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 9, 2007 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 23, 2007 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 23, 2007 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Jul 23, 2007 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Jul 23, 2007 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Jan 23, 2007 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 23, 2007 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 22, 2006 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 21, 2006 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 21, 2006 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 29, 2006 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 29, 2006 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 7, 2006 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 16, 2006 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 16, 2006 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 17, 2005 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 17, 2005 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 8, 2005 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 24, 2005 | NWAP | NEW APPLICATION ENTERED | — |